RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Apollo Therapeutics

Apollo Therapeutics

Apollo Therapeutics is a portfolio biopharmaceutical company that develops new medicines.

Latest funding

$226.5M Series B+ ·

Source: fundraisingfox.com

Funding history ↓
Website: apollotx.com.
Category: Health and bio.
Sectors: Biopharma, Biotechnology, Clinical Trials, Health Care, Medical.
Stage: Series B+.
Based in: Cambridge, United Kingdom.
Last round: Sep 6, 2023 · 1,167 days ago.
Headcount: 51–100 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredMar 21, 2021 (5 years old)
About Apollo Therapeutics

It translates breakthroughs in biology and basic medical research into novel therapeutics. The company identifies and advances pre-clinical and clinical-stage therapeutic programs.

Funding rounds

DateRoundAmountLeadSource
Series B+$226.5M—fundraisingfox.com

Timeline

  1. Website created

Companies like Apollo Therapeutics

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/apollo-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy